-
1
Semaglutide, type 2 diabetes, and the risk of nonarteritic anterior ischemic optic neuropathy
Published 2025-01-01Subjects: “…Nonarteritic anterior ischemic optic neuropathy…”
Get full text
Article -
2
Investigating Elevated E-Selectin and P-Selectin Levels in Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patients: The Stepping Stone to a Future Clinical Approach
Published 2024-10-01Subjects: “…non-arteritic anterior ischemic optic neuropathy…”
Get full text
Article -
3
Ischemic optic neuropathy: a review
Published 2024-12-01Subjects: “…ischemic optic neuropathy…”
Get full text
Article -
4
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes
Published 2024-12-01Subjects: “…Nonarteritic anterior ischemic optic neuropathy…”
Get full text
Article -
5
Risk factors of developing non-arteric ischemic optic neuropathy in patients with type 2 diabetes mellitus: a single-center retrospective cohort study
Published 2025-02-01Subjects: “…non-arteric ischemic optic neuropathy…”
Get full text
Article -
6
Quantifying the spatial patterns of retinal ganglion cell loss and progression in optic neuropathy by applying a deep learning variational autoencoder approach to optical coherence...
Published 2025-02-01Subjects: “…non-arteritic anterior ischemic optic neuropathy (NAION)…”
Get full text
Article -
7
COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?
Published 2021-07-01Subjects: “…arteritic anterior ischemic optic neuropathy…”
Get full text
Article